Source: Business Standard

Biomeva: Asahi Glass buys German biopharmaceutical CMO Biomeva

With this acquisition, AGC's life science business will be able to expand its geographic coverage and offer a wider range of capacities

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thomas Pultar's photo - CEO of Biomeva

CEO

Thomas Pultar

CEO Approval Rating

69/100

Read more